Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 of  890 نتائج ل ""IMMUNE checkpoint inhibitors""

فلترة النتائج

Publication : cancer medicine فلترة بواسطة : موضوع
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer.

  • Authors : Shin DS; Department of Medicine, Division of Hematology-Oncology, VAGLAHS/David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California, USA.; Basak S

Subjects: CTLA-4 Antigen*/CTLA-4 Antigen*/CTLA-4 Antigen*/antagonists & inhibitors ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/pharmacology ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use

  • Source: Cancer medicine [Cancer Med] 2024 May; Vol. 13 (9), pp. e7212.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study.

  • Authors : Zheng Y; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.; Chen Z

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Myocarditis*/Myocarditis*/Myocarditis*/chemically induced ; Myocarditis*/Myocarditis*/Myocarditis*/epidemiology

  • Source: Cancer medicine [Cancer Med] 2024 May; Vol. 13 (10), pp. e7233.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Artificial neural network identified a 20-gene panel in predicting immunotherapy response and survival benefits after anti-PD1/PD-L1 treatment in glioblastoma patients.

  • Authors : Wang Y; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking UnionMedical College, Beijing, China.; Wang Z

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics ; Glioblastoma*/Glioblastoma*/Glioblastoma*/mortality

  • Source: Cancer medicine [Cancer Med] 2024 May; Vol. 13 (9), pp. e7218.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Off-label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center.

  • Authors : Gikandi A; Harvard Medical School, Boston, Massachusetts, USA.; Chi SN

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Glioma*/Glioma*/Glioma*/drug therapy; Young Adult

  • Source: Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (8), pp. e7154.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: A systematic review and meta-analysis.

  • Authors : Gao X; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.; Zhu Y

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy; Humans

  • Source: Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (24), pp. 21873-21884. Date of Electronic Publication: 2023 Dec 08.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Restriction site associated DNA sequencing for tumour mutation burden estimation and mutation signature analysis.

  • Authors : McGuinness CF; Department of Biochemistry, University of Otago, Dunedin, New Zealand.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Subjects: Immune Checkpoint Inhibitors* ; Breast Neoplasms*; Animals

  • Source: Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (23), pp. 21545-21560. Date of Electronic Publication: 2023 Nov 17.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective study.

  • Authors : Guo J; The Comprehensive Cancer Centre, Department of Oncology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.; Department of Oncology, China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China.

Subjects: Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/drug therapy ; Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/pathology ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use

  • Source: Cancer medicine [Cancer Med] 2023 Nov; Vol. 12 (22), pp. 20699-20711. Date of Electronic Publication: 2023 Nov 06.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Proton pump inhibitors stabilize the expression of PD-L1 on cell membrane depending on the phosphorylation of GSK3β.

  • Authors : Gao L; Department of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.; Liu Y

Subjects: Proton Pump Inhibitors*/Proton Pump Inhibitors*/Proton Pump Inhibitors*/pharmacology ; B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism ; B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/genetics

  • Source: Cancer medicine [Cancer Med] 2024 May; Vol. 13 (10), pp. e7083.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Toxicity profiles of immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis.

  • Authors : Dang S; Cancer Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.; Li X

Subjects: Carcinoma* ; Head and Neck Neoplasms*/Head and Neck Neoplasms*/Head and Neck Neoplasms*/drug therapy; Humans

  • Source: Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (7), pp. e7119.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Meta-analysis of PD-(L)1 inhibitor plus chemotherapy versus chemotherapy as first-line treatment in extensive-stage small-cell lung cancer.

  • Authors : Lu J; Department of Radiation Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.; Medical School of Chinese PLA, Beijing, China.

Subjects: Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/pathology ; Small Cell Lung Carcinoma*/Small Cell Lung Carcinoma*/Small Cell Lung Carcinoma*/drug therapy

  • Source: Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (17), pp. 17924-17933. Date of Electronic Publication: 2023 Aug 11.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 of  890 نتائج ل ""IMMUNE checkpoint inhibitors""